HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Udaya S Tantry Selected Research

Adenosine Diphosphate (ADP)

1/2021Platelet Reactivity and Coagulation Markers in Patients with COVID-19.
10/2020Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study.
1/2020Assessing platelet reactivity after drug eluting stent implantation: state of the art.
1/2018Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes.
1/2016Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study.
12/2013Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
11/2013Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account.
1/2013Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring.
1/2013The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response.
7/2012Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Udaya S Tantry Research Topics

Disease

50Hemorrhage
10/2021 - 02/2007
40Acute Coronary Syndrome
08/2022 - 07/2006
39Coronary Artery Disease (Coronary Atherosclerosis)
06/2021 - 11/2005
37Thrombosis (Thrombus)
02/2022 - 01/2005
23Myocardial Infarction
02/2021 - 01/2005
16Stroke (Strokes)
02/2021 - 01/2006
13Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 05/2007
12Inflammation (Inflammations)
02/2022 - 12/2006
12COVID-19
02/2022 - 11/2020
7Atherosclerosis
01/2020 - 05/2015
6Peripheral Arterial Disease
11/2020 - 06/2015
5Ischemia
02/2022 - 02/2007
5Thrombophilia
02/2022 - 02/2014
5Atrial Fibrillation
10/2021 - 07/2011
5Thromboembolism
01/2018 - 03/2008
5ST Elevation Myocardial Infarction
01/2017 - 01/2012
3Ischemic Stroke
10/2019 - 03/2008
3Pathologic Constriction (Stenosis)
01/2018 - 04/2016
3Type 2 Diabetes Mellitus (MODY)
12/2016 - 11/2009
2Venous Thrombosis (Deep-Vein Thrombosis)
10/2021 - 09/2013
2Vascular Diseases (Vascular Disease)
01/2019 - 12/2016
2Wounds and Injuries (Trauma)
05/2017 - 11/2002
2Infarction (Infarctions)
01/2017 - 02/2009
2Hypersensitivity (Allergy)
01/2017 - 09/2011
2Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2015 - 10/2011
2Transient Ischemic Attack
06/2015 - 08/2012
2Heart Failure
02/2014 - 09/2013
2Coronary Disease (Coronary Heart Disease)
01/2013 - 01/2005
2Unstable Angina
11/2012 - 01/2010
2Necrosis
12/2006 - 03/2005
1Thrombocytopenia (Thrombopenia)
01/2022
1Cytokine Release Syndrome
01/2022
1Hyperemia
06/2021
1Acute Lung Injury
01/2021
1Heart Arrest (Cardiac Arrest)
10/2020
1Reperfusion Injury
10/2020

Drug/Important Bio-Agent (IBA)

64Clopidogrel (Plavix)FDA Link
06/2021 - 01/2005
57Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 11/2005
15Adenosine Diphosphate (ADP)IBA
01/2021 - 10/2007
11AnticoagulantsIBA
10/2021 - 07/2011
10ThrombinFDA Link
11/2020 - 05/2006
10TicagrelorIBA
01/2020 - 12/2009
10Pharmaceutical PreparationsIBA
02/2019 - 01/2006
9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2008
9FibrinIBA
12/2021 - 05/2006
9Prasugrel HydrochlorideFDA Link
10/2021 - 03/2008
72'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 01/2010
6Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2015 - 10/2005
6Cytochrome P-450 CYP2C19IBA
05/2014 - 12/2010
5vorapaxarIBA
01/2020 - 10/2011
5LipidsIBA
04/2016 - 12/2008
4Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2018 - 01/2005
4Warfarin (Coumadin)FDA LinkGeneric
01/2018 - 07/2011
3Platelet Membrane Glycoprotein IIbIBA
08/2022 - 01/2005
3Fibrinogen (Factor I)FDA Link
01/2022 - 01/2021
3C-Reactive ProteinIBA
11/2020 - 12/2007
3Phenobarbital (Luminal)FDA Link
01/2018 - 04/2016
3Glycoproteins (Glycoprotein)IBA
01/2015 - 01/2005
3Proton Pump InhibitorsIBA
09/2014 - 01/2010
2fibrin fragment D (D-dimer)IBA
01/2022 - 01/2021
211-dehydro-thromboxane B2IBA
07/2021 - 01/2020
2omega-Chloroacetophenone (Mace)IBA
02/2021 - 11/2020
2AntibodiesIBA
12/2020 - 05/2016
2CollagenIBA
10/2020 - 11/2002
2Blood Coagulation Factors (Coagulation Factor)IBA
01/2019 - 10/2007
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2018 - 08/2017
2Genetic Markers (Genetic Marker)IBA
04/2016 - 05/2015
2AntithrombinsIBA
12/2015 - 09/2013
2thienopyridineIBA
07/2015 - 12/2006
2P-SelectinIBA
04/2015 - 06/2009
2Cilostazol (Pletal)FDA LinkGeneric
01/2015 - 11/2012
2bivalirudin (Angiomax)FDA Link
01/2015 - 02/2009
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2012 - 10/2007
2Eptifibatide (Integrilin)FDA Link
02/2009 - 02/2007
1Tirofiban (Aggrastat)FDA Link
08/2022
1Metformin (Glucophage)FDA LinkGeneric
02/2022
1VaccinesIBA
01/2022
18-Hydroxy-2'-DeoxyguanosineIBA
07/2021
1Fatty Acid-Binding ProteinsIBA
07/2021
1Hemostatics (Antihemorrhagics)IBA
06/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Plasminogen Activator Inhibitor 1IBA
01/2021
1Peptides (Polypeptides)IBA
10/2020
1ColchicineFDA LinkGeneric
10/2020
1AngiopoietinsIBA
10/2020
1tocilizumab (atlizumab)FDA Link
10/2020
1RevaceptIBA
10/2020
1Phosphotransferases (Kinase)IBA
10/2020
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2020
1Investigational DrugsIBA
01/2020
1RivaroxabanIBA
01/2020

Therapy/Procedure

81Therapeutics
05/2021 - 05/2006
32Percutaneous Coronary Intervention
08/2022 - 07/2006
21Stents
01/2022 - 01/2005
8Secondary Prevention
01/2020 - 08/2012
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2018 - 08/2011
3Drug Therapy (Chemotherapy)
10/2020 - 08/2013
3Drug-Eluting Stents
01/2020 - 01/2007
2Heart-Assist Devices
11/2018 - 11/2017
1Induced Hypothermia
10/2020